Interval Colorectal Cancers in a Fecal Immunochemical Test-Based Screening Program

Wen-Feng Hsu1, Uri Ladabaum2, Chiu-Wen Su1

  • 1Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

JAMA Network Open
|July 28, 2025
PubMed
Summary

Interval colorectal cancer (CRC) is more common after colonoscopy than after a negative fecal immunochemical test (FIT). Higher adenoma detection rates (ADR) during colonoscopy correlate with worse survival, indicating potential limitations in current screening methods.